How the Rise in Geriatric Population is Driving Growth of Acute Kidney Injury Market: New Report Analyzes
Market players are focusing on technology expansion to attain a competitive edge. DUBAI, UAE / ACCESSWIRE / February 4, 2021...
Staff
Alkame Receives Initial PPE Product Order for Canadian Market
LAS VEGAS, NV / ACCESSWIRE / February 4, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly traded holding company...
How the Increase in Demand by End Users like hospitals and Clinics is Spurring the Growth of the Respiratory Devices Market – Future Market Insights Report Analyzes
Key market players believe the rise in respiratory ailments pushing the development and innovation of respiratory devices will be a...
Stella Diagnostics Announces Partnership with mProbe Laboratories
PALO ALTO, CA / ACCESSWIRE / February 4, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced...
UTILITY Therapeutics Announces Capital Raise and 2021 Corporate Objectives
Financing from new and existing investors to advance two European-approved antibiotics for the U.S. market Pivmecillinam Pre-NDA meeting with the...
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds
MONTREAL, QC / ACCESSWIRE / February 4, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
Aytu BioScience to Report Second Fiscal 2021 Results and Provide Business Update on Thursday, February 11, 2021
Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 4, 2021 / Aytu BioScience,...
Secarna Pharmaceuticals Appoints Alexander Gebauer, MD, PhD as CEO and Managing Director
MUNICH/MARTINSRIED, GERMANY / ACCESSWIRE / February 4, 2021 / Secarna Pharmaceuticals GmbH & Co. KG ("Secarna"), a biopharmaceutical company focusing...
Neutra Focused on Growth
KATY, TX / ACCESSWIRE / February 4, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") has decided to...
CureVac Announces Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 4, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
Access to industry-leading genomic database and real-world evidence designed to optimize trial design, site selection, clinical trial matching and translational...
Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer...
Indegene Releases The Healthcare Customer Experience Playbook – A Prescriptive Guide to Orchestrating Outstanding HCP Experiences
At least 1 in 3 Health Care Professionals (HCPs) are not satisfied with their channel experience Source: The Healthcare CX...
Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
GCAC Announces Health Canada Medical Cannabis Sales License
Efixii App Gains Health Canada Cannabis-Consultation Feature for $600 Million MarketVANCOUVER, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Global...
ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD
Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services...
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2020 Financial Results and Corporate Update
NOVATO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of a private...
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
3 out of 4 intubated patients were discharged after treatment2 out of 4 patients were extubated within 24 hours of...
InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering
TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the...